Donor and recipient-transforming growth factor-beta 1 polymorphism and cardiac transplant-related coronary artery disease

Transplant Immunology

Volumn 13, Issue 3, 2004, Pages 211-217

  Densem, C G ^a,c   Hutchinson, I V ^b   Yonan, N ^a   Brooks, N H ^a  

^a WYTHENSHAWE HOSPITAL   (United Kingdom)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c BLACKPOOL VICTORIA HOSPITAL   (United Kingdom)

Author keywords

Cardiac transplantation; Coronary vasculopathy; Polymorphism; TGF beta1

Indexed keywords

TRANSFORMING GROWTH FACTOR BETA1;

ALLELE; ANGIOCARDIOGRAPHY; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE EXPRESSION; GENOTYPE; GRAFT REJECTION; HEART TRANSPLANTATION; HOMOZYGOTE; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MULTIVARIATE ANALYSIS; ORGAN DONOR; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; RECIPIENT; STATISTICAL SIGNIFICANCE; VASCULAR DISEASE;

CORONARY ANGIOGRAPHY; CORONARY ARTERIOSCLEROSIS; GENOTYPE; GREAT BRITAIN; HEART TRANSPLANTATION; HUMANS; IMMUNOSUPPRESSION; PERIOPERATIVE CARE; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RISK FACTORS; TISSUE DONORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 4744358701     PISSN: 09663274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trim.2004.06.005     Document Type: Article

References (42)

1. M.E. Billingham Cardiac transplant arteriosclerosis Transplant Proc. 19 Suppl. 5 1987 19 25
2. D.E. Johnson, S.Z. Gao, J.S. Schroeder, W.M. DeCampi, and M.E. Billingham The spectrum of coronary artery pathologic findings in human cardiac allografts J. Heart Lung Transplant 8 1989 349 359
3. M.E. Billingham Pathology of graft vascular disease after heart and heart-lung transplantation and its relationship to obliterative bronchiolitis Transplant Proc. 27 1995 2013 2016
4. W.A. Border, and N.A. Noble Transforming growth factor beta in tissue fibrosis N. Engl. J. Med. 331 1994 1286 1292
5. P.O. Vaillant, J.-M. Menard, N. Vignaud, and Y. Martinet The role of cytokines in human lung fibrosis Monaldi Arch. Chest Dis. 51 1996 145
6. I.V. Hutchinson, D.M. Turner, D. Sankaran, M.R. Awad, and P.J. Sinnott Influence of cytokine genotypes on allograft rejection Transplant Proc. 30 1998 862 863
7. M.R. Awad, A. El-Gamel, P. Hasleton, D.M. Turner, P.J. Sinnott, and I.V. Hutchinson Genotypic variation in the transforming growth factor beta-1 gene: association with transforming growth factor-beta1 production, fibrotic lung disease and graft fibrosis after lung transplantation Transplantation 66 1998 1014 1020
8. F. Cambien, S. Ricard, A. Troesch, C. Mallet, L. Generenaz, and A. Evans Polymorphisms of the transforming growth factor-beta 1 gene in relation to myocardial infarction and blood pressure. The Etude Cas-Temoin de i'Infarctus du Myocarde (ECTIM) Study Hypertension 28 1996 881 887
9. I.V. Hutchinson, D.M. Turner, D. Sankaran, M.R. Awad, and P.J. Sinnott Influence of cytokine genotypes on allograft rejection Transplant Proc. 30 1998 862 863
10. M. Yokota, S. Ichihara, T.L. Lin, N. Nakashima, and Y. Yamada Association of a T29→C polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to myocardial infarction in Japanese Circulation 101 2000 2783 2787
11. Y. Yamada, M. Fujisawa, F. Ando, N. Niino, M. Tanaka, and H. Shimokata Association of a polymorphism of the transforming growth factor-beta1 gene with blood pressure in Japanese individuals J. Hum. Genet. 47 2002 243 248
12. V. Hinke, T. Seck, C. Clanget, C. Scheidt-Nave, R. Ziegler, and J. Pfeilschifter Association of transforming growth factor-beta1 (TGFbeta1) T29→C gene polymorphism with bone mineral density (BMD), changes in BMD, and serum concentrations of TGF-beta1 in a population-based sample of postmenopausal German women Calcif. Tissue Int. 69 2001 315 320
13. C.G. Densem, I.V. Hutchinson, A. Cooper, N. Yonan, and N.H. Brooks Polymorphism of the Transforming growth factor-beta 1 gene correlates with the development of coronary vasculopathy following cardiac transplantation J. Heart Lung Transplant 19 2000 551 556
14. C.T.J. Holweg, C.C. Baan, A.H.M.M. Balk, H.G.M. Niesters, A.P.W.M. Maat, and P.M.G. Mulder The transforming growth factor-1 codon 10 gene polymorphism and accelerated graft vascular disease after clinical heart transplantation Transplantation 71 2001 1463 1467
15. M.E. Billingham, N.R. Cary, M.E. Hammond, J. Kemnitz, C. Marboe, and H.A. McCallister A working formulation for the standardisation of nomenclature in the diagnosis of heart and lung rejection: Heart Rejection Study Group J. Heart Lung Transplant 9 1990 587 592
16. S.Z. Gao, S.A. Hunt, J.S. Schroeder, E.L. Alderman, I.R. Hill, and E.B. Stinson Early development of accelerated graft coronary artery disease: risk factors and course J. Am. Coll. Cardiol. 28 1996 673 679
17. M.T. Olivari, D.C. Homans, R.F. Wilson, S.H. Kubo, and W.S. Ring Coronary artery disease in cardiac transplant patients receiving triple drug immunosuppressive therapy Circulation 80 Suppl. III 1989 III-111 III-115
18. D.M. Little, L.D. Haynes, T. Alam, J.G. Geraghty, H.W. Sollinger, and D.A. Hullett Does transforming growth factor beta 1 play a role in the pathogenesis of chronic allograft rejection? Transplant Int. 12 1999 393 401
19. T. Aziz, P. Haselton, A. Wynn Hann, N. Yonan, A. Deiraniya, and I.V. Hutchinson Transforming growth factor-beta in relation to cardiac allograft vasculopathy after heart transplantation J. Thorac. Cardiovasc. Surg. 119 2000 700 708
20. T. Aziz, R.A. Saad, M. Burgess, N. Yonan, P. Hasleton, and I.V. Hutchinson Transforming growth factor beta and myocardial dysfunction following heart transplantation Eur. J. Cardiothorac. Surg. 20 2001 177 186
21. A. El-Gamel, E. Sim, P. Hasleton, J. Hutchinson, N. Yonan, and J. Egan Transforming growth factor beta (TGF-b) and obliterative bronchiolitis following pulmonary transplantation J. Heart Lung Transplant 18 1999 828 837
22. A. El-Gamel, M.R. Awad, E. Sim, P. Haselton, N. Yonan, and J. Egan Transforming growth factor-β1 and lung allograft fibrosis Eur. J. Cardiothorac. Surg. 13 1998 424 430
23. M.L. Nicholson, G.R. Bicknell, S.T. Williams, and P.N. Furness Is TGF-β a profibrogenic cytokine in human renal transplant? Transplant Proc. 30 1999 952
24. I.V. Hutchinson The role of transforming growth factor-? in transplant rejection Transplant Proc. 31 Suppl. 7A 1999 9S 13S
25. D. Sankaran, S. Asharaf, A. Asderakis, I.S. Roberts, C.D. Short, and P.A. Dyer Cytokine gene polymorphisms predict acute graft rejection following renal transplantation Kidney Int. 56 1999 281 289
26. Y. Yamada, A. Miyauchi, J. Goto, Y. Takagi, H. Okuizumi, and M. Kanematsu Association of a polymorphism of the transforming growth factor-beta1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women J. Bone Miner. Res. 13 1998 1569 1576
27. D.J. Grainger, K. Heathcote, M. Chiano, H. Snieder, P.R. Kemp, and J.C. Metcalfe Genetic control of the circulating concentration of transforming growth factor type beta1 Hum. Mol. Genet. 8 1999 93 97
28. S.M. Wahl, D.A. Hunt, L.M. Wakefield, N. McCartney-Francis, L.M. Wahl, and A.B. Roberts Transforming growth factor type (induces monocyte chemotaxis and growth factor production Proc. Natl. Acad. Sci. U. S. A. 84 1987 5788 5792
29. R.A. Majack Beta-type transforming growth factor specifies organizational behaviour in vascular smooth muscle cell cultures J. Cell Biol. 105 1987 465 471
30. E.J. Battegay, E.W. Raines, R.A. Seifert, D.F. Bowen-Pope, and R. Ross TGF-β induces bimodal proliferation of connective tissue cells via complex control of an autocrine PDGF loop Cell 63 1990 515 524
31. S. Nikol, J.M. Isner, J.G. Pickering, M. Kearney, G. Leclerc, and L. Weir Expression of transforming growth factor-β1 is increased in human vascular restenosis lesions J. Clin. Invest. 90 1992 1582 1592
32. M.W. Majesky, V. Lindner, D.R. Twardzik, S.M. Schwartz, and M.A. Reidy Production of transforming growth factor β1 during repair of arterial injury J. Clin. Invest. 88 1991 904 910
33. Y.G. Wolf, L.M. Rasmussen, and E. Ruoslahti Antibodies against transforming growth factor-β1 suppresses intimal hyperplasia in a rat model J. Clin. Invest. 93 1994 1172 1178
34. J.G. Motwani, and E.J. Topol Aortocoronary saphenous vein graft disease; pathogenesis, predisposition, and prevention Circulation 97 1998 916 931
35. L.W. Miller Transplant coronary artery disease: editorial J. Heart Lung Transplant 11 1992 S1 S4
36. M.S. Kemma, H.A. Valantine, S.A. Hunt, J.S. Schroeder, Y.-D. Chen, and G.M. Reaven Metabolic risk factors for atherosclerosis in heart transplant recipients Am. Heart J. 128 1994 68 72
37. C.B. Treasure, and R.W. Alexander Relevance of vascular biology to the ischaemic syndromes of coronary atherosclerosis Cardiovasc. Drugs Ther. 9 1995 13 19
38. H.A. de Groot-Kruseman, C.C. Baan, H.G.M. Niesters, A.P.W.M. Maat, A.H.M.M. Balk, and W. Weimar Increased intragraft expression of TGF-β1 mRNA in patients with graft vascular disease after clinical heart transplantation J. Heart Lung Transplant 18 1999 52 (abstract)
39. F.S. Shihab, T. Yamamoto, C.C. Nast, A.H. Cohen, N.A. Noble, and L.I. Gold Transforming growth factor-beta and matrix protein expression in acute and chronic rejection of human renal allografts J. Am. Soc. Nephrol. 6 1995 286 294
40. A.C. Anyanwu, C.A. Rogers, and A.J. Murday Variations in cardiac transplantation: comparisons between the United Kingdom and the United States J. Heart Lung Transplant 18 1999 297 303
41. G.E. Sarris, K.E. Moore, J.S. Schroeder, S.A. Hunt, M.B. Fowler, and H.B. Valantine Cardiac transplantation: the Stanford experience in the cyclosporine era J. Thorac. Cardiovasc. Surg. 108 1994 240 252
42. P. Mercer, L. Sharples, J. Edmunds, R. Gittins, J. Baines, and J. Wallwork Evaluating the donor pool: impact of using hearts from donors over the age of 49 years Transpl. Int. 11 Suppl. 1998 S424 S429